MDL 3140

Last Updated: August 8, 2026 | Reviewed by: TortAdvisor Editorial Team | Primary Sources: U.S. District Court, N.D. Florida (MDL 3140); AboutLawsuits.com; FDA Quick Answer: A confidential Depo-Provera lawsuit settlement now covers nearly 6,300 federal meningioma brain-tumor claims after attorneys finalized a Master Settlement Agreement on July 27, 2026. Full eligibility and payout details will [...]

Quick Answer: The Depo-Provera lawsuit statute of limitations typically runs one to six years from the date of diagnosis, depending on your state and whether that state applies a "discovery rule." Missing your state's deadline can bar your claim entirely, so confirming your exact filing window with an attorney as soon as possible is critical. [...]

The Depo-Provera Rule 702 hearing on general causation moves to July 27, 2026. Here's what the ruling could mean if your case isn't covered by the settlement.

Quick Answer: A global Depo-Provera settlement agreement was announced on June 15, 2026, covering claims that the injectable birth control caused meningioma brain tumors. The parties signed a private Master Settlement Agreement on July 21, 2026 and estimated that roughly 80% of MDL plaintiffs would be eligible under it. BrownGreer PLC was appointed Settlement Administrator [...]

Depo-Provera MDL No. 3140 Update Depo-Provera Daubert Hearing 2026: June 24 Date, 6,000 Cases and What It Means The Depo-Provera Daubert hearing scheduled for June 24–26, 2026 is a pivotal Rule 702 hearing in the federal meningioma litigation against Pfizer and related defendants. With roughly 6,000 filed or reported claims tied to Depo-Provera and [...]